Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 181.09M P/E - EPS this Y 72.00% Ern Qtrly Grth -
Income -33.2M Forward P/E -10.65 EPS next Y 7.80% 50D Avg Chg 23.00%
Sales 585.17M PEG - EPS past 5Y 14.28% 200D Avg Chg -5.00%
Dividend N/A Price/Book 0.66 EPS next 5Y - 52W High Chg -74.00%
Recommedations 1.70 Quick Ratio 1.04 Shares Outstanding 25.79M 52W Low Chg 93.00%
Insider Own 10.30% ROA 0.40% Shares Float 23.20M Beta 3.20
Inst Own 20.59% ROE -12.66% Shares Shorted/Prior 1.17M/1.07M Price 7.03
Gross Margin 29.64% Profit Margin -5.67% Avg. Volume 496,050 Target Price 15.50
Oper. Margin -6.10% Earnings Date May 10 Volume 179,131 Change -0.85%
About Inotiv, Inc.

Inotiv, Inc. provides nonclinical and analytical drug discovery and development services to the pharmaceutical and medical device industries. It operates through two segment: Discovery and Safety Assessment (DSA), and Research Models and Services (RMS). The DMS segment manufactured scientific instruments for life sciences research and the related software for use by pharmaceutical companies, universities, government research centers, and medical research institutions under the Company's BASi product line. The RMS segment engages in commercial production and sales of research models, diets, bedding, and bioproducts. The company offers research and discovery services, including computational toxicology, disease pharmacology, DMPK, safety pharmacology, discovery bioanalysis, exploratory, surgical models and medical device, and cell and molecular biology; non-clinical safety assessment includes general and genetic toxicology, regulated bioanalysis, carcinogenicity studies, and development and reproductive toxicology; pathology services, such as histology, digital, clinical, and medical device pathology; bioanalysis includes nonregulated discovery bioanalysis, biotherapeutics, and regulated preclinical and clinical bioanalysis; proteomics; and consulting services, as well as model and research services. The company operates in the United States, the Netherlands, and internationally. The company was formerly known as Bioanalytical Systems, Inc. and changed its name to Inotiv, Inc. in March 2021. Inotiv, Inc. was incorporated in 1974 and is headquartered in West Lafayette, Indiana.

Inotiv, Inc. News
05/02/24 Investors push Inotiv (NASDAQ:NOTV) 16% lower this week, company's increasing losses might be to blame
04/29/24 Inotiv, Inc. to Report Fiscal 2024 Second Quarter Financial Results and Host Conference Call on Friday, May 10, 2024
04/03/24 Inotiv (NOTV) Is a Great Choice for 'Trend' Investors, Here's Why
04/02/24 Why Fast-paced Mover Inotiv (NOTV) Is a Great Choice for Value Investors
03/25/24 Is Inotiv (NOTV) a Great Value Stock Right Now?
03/18/24 Are Investors Undervaluing Collegium Pharmaceutical (COLL) Right Now?
03/18/24 Here's Why Momentum in Inotiv, Inc. (NOTV) Should Keep going
03/12/24 Rocket Stocks: 3 Picks That Could Skyrocket Your Portfolio by 2025
03/07/24 3 Stocks That Could Fast-Track Your Millionaire Status
03/07/24 Inotiv, Inc. (NOTV) is a Great Momentum Stock: Should You Buy?
03/07/24 Despite Fast-paced Momentum, Inotiv, Inc. (NOTV) Is Still a Bargain Stock
03/01/24 Should Value Investors Buy Inotiv (NOTV) Stock?
02/29/24 Here's What Could Help Inotiv, Inc. (NOTV) Maintain Its Recent Price Strength
02/27/24 3 Overlooked Stocks with Potential for 500% Growth by 2025
02/20/24 Millionaire-Makers: 3 Game-Changing Stocks Ready for Historic Gains
02/19/24 Inotiv, Inc. (NOTV) Is Attractively Priced Despite Fast-paced Momentum
02/14/24 Are Investors Undervaluing Inotiv (NOTV) Right Now?
02/11/24 Earnings Update: Here's Why Analysts Just Lifted Their Inotiv, Inc. (NASDAQ:NOTV) Price Target To US$15.50
02/09/24 Inotiv, Inc. (NASDAQ:NOTV) Q1 2024 Earnings Call Transcript
02/09/24 Inotiv First Quarter 2024 Earnings: Beats Expectations
NOTV Chatroom

User Image Apes_Strong Posted - 11 hours ago

$NOTV something seems wrong Too much selling going into earnings They announced the date of their release, but didn’t preannounce any bad news That should mean everything is okay with guidance ???

User Image DarleyMark Posted - 12 hours ago

$NOTV NOTV focuses on small/medium target audiences. Such as biotech's, universities etc, not so much big pharma in the business model. NOTV thinks there's a potential gap in the market for what they do. The stock is volatile as we all know, it ran off good news, got FOMOd a little and hit some litigation news. The litigation news being an old shareholder suit that NOTV tried to appeal and got denied, out of nowhere. This doesn't mean the waves will stop, the news practically changed nothing. The case has been going on for years and could be another year+ lol. Seeing rate cuts would be crazy bullish for NOTV.

User Image Apes_Strong Posted - 14 hours ago

$NOTV Uggg I’ve been calling around for 2 weeks trying to understand the drop from $11 with no bounce, and especially if guidance in Feb was for 75-80 mm EBITDA for the year So I finally reached a fund short the stock They ask me: who do you think are notv’s largest customers for NHPs I started thinking abiut it and had to admit I didn’t know …. His answer: CRL

User Image BobbyLP Posted - 18 hours ago

$NOTV one more week until earnings. I believe they're doing it pre market on Friday? A sign of confidence in themselves?

User Image RemitTekram Posted - 19 hours ago

$NOTV CHEERS TO THE BULLS for being >+10% on the day!! My fourth stock to do so today.

User Image Botmax Posted - 20 hours ago

$NOTV Jobs data is good for the case for rate cuts which is bullish for biotech which is bullish for Inotiv.

User Image Losingmoneyprobably Posted - 1 day ago

$NOTV This was at $10 one month ago. Nothing has changed except the stock price. I guess I’m not worried

User Image SwingTradeDrew Posted - 2 days ago

$NOTV Back in for a second run.

User Image RemitTekram Posted - 2 days ago

$NOTV I've been buying daily. Seems to be paying off. I take the risk of being in before Joe's green dots begin. Definitely a risk, but has paid off many times in the past.

User Image RemitTekram Posted - 2 days ago

$NOTV Need bullish confirmation today after yesterday's doji.

User Image mattgross Posted - 04/30/24

$NOTV Finally we reached bottom!

User Image Joaquinalbert Posted - 04/30/24

$NOTV it's like clock work. Let the stock run up and then hit it with about 20k of down pressure shares and bam. The stock runs out of gas. Got to say that whatever direction this heads it goes pretty hard for a while.

User Image RemitTekram Posted - 04/30/24

$NOTV Hmm. Tutes still selling out of this. 6 months ago this was 31% owned by them, now only 20%. How can it be a steal if they lost a third of their tutes.

User Image Botmax Posted - 04/29/24

$NOTV Interesting that every call since Monkey Gate 🐒🐵 thats 6 to date were held after hours. This earnings call is Friday before trade opens.

User Image Stock_Titan Posted - 04/29/24

$NOTV Inotiv, Inc. to Report Fiscal 2024 Second Quarter Financial Results and Host Conference Call on Friday, May 10, 2024 https://www.stocktitan.net/news/NOTV/inotiv-inc-to-report-fiscal-2024-second-quarter-financial-results-libud7b62dv4.html

User Image RemitTekram Posted - 04/29/24

$NOTV They really are going to take it down to at least $3.25. Bastards. That why you always buy in over multiple days/weeks to really nail it. You just never know .... unless you have Joe's code.

User Image Redneck_Capital Posted - 04/29/24

$NOTV seeing if I can get 2.50 for some Oct 5P, and if I can, I'll sell maybe 50 contracts. Worst case, I add 5K more shares at 2.50 cost basis on assignment, or I'll collect the premium on the rise back up :)

User Image RemitTekram Posted - 04/29/24

$NOTV Buying all morning.

User Image Bassfisher89 Posted - 04/28/24

$NOTV Insane drop. The lawsuit will be a drag for sure, but litigation payout will be pennies on the dollar, if successful, which is not likely. The main issue is legal fees will be through the roof now and that will hamper EBITDA and take focus away from C suite as they navigate the crybaby case.

User Image SocioCobb Posted - 04/26/24

$NOTV $NARI & $LXRX all popped up on my radar today at 10:14 am. Why?

User Image RemitTekram Posted - 04/26/24

$NOTV Still slowly buying this falling knife knowing it can continue. I'll use the size of my trades to keep the average low till it turns. 🤞

User Image RemitTekram Posted - 04/26/24

$NOTV So down to $3.25 we go I guess.

User Image RemitTekram Posted - 04/26/24

$NOTV Latest on court case: https://law.justia.com/cases/federal/district-courts/indiana/inndce/4:2022cv00045/111425/75/

User Image Jasooon Posted - 04/26/24

$NOTV, dam why the big drop in past month!?

User Image Apes_Strong Posted - 04/25/24

$NOTV 75,000 shares takes us green Let’s go

User Image Apes_Strong Posted - 04/25/24

$NOTV 150,000 shares of real buying probably flips this green n the day

User Image Apes_Strong Posted - 04/25/24

$NOTV just no buyers in a hurricane

User Image Apes_Strong Posted - 04/25/24

$NOTV looking at it objectively , it’s only 250,000 shares traded If you assume double printing for market makers, it’s really only 125

User Image Joaquinalbert Posted - 04/25/24

$NOTV looks like this may be in response to $crl coming out against a shareholder proposal on more nhp disclosure yesterday.

User Image RemitTekram Posted - 04/25/24

$NOTV Yumm. Yes please. Falling knife may hurt, but it may be an opportunity too.

Analyst Ratings
Jefferies Buy Feb 9, 24
Craig-Hallum Buy Dec 12, 23
Wells Fargo Overweight Jul 20, 23
Jefferies Hold Jan 19, 23
Lake Street Buy Jan 11, 23
Lake Street Hold Nov 18, 22
Jefferies Buy Oct 4, 22
Lake Street Buy Aug 11, 22
Lake Street Buy Jan 31, 22
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Garrett Michael Chief Commercial Off.. Chief Commercial Officer Dec 14 Buy 2.829 5,000 14,145 16,467 12/15/23
Beattie John Gregory Chief Operating Offi.. Chief Operating Officer Dec 14 Buy 3.1238 47,966 149,836 111,761 12/15/23
Pitchford William D Chief Human Resource.. Chief Human Resources Officer Dec 09 Sell 5.8246 2,123 12,366 74,051 12/29/22
Neff R Matthew Director Director Dec 01 Sell 6.12 1,000 6,120 62,388 12/02/22
Harkness James Chief Operating Offi.. Chief Operating Officer, RMS Mar 15 Buy 19.29 38,968 751,693 38,968 03/16/22
Downing Philip A Sr. VP, Preclinical.. Sr. VP, Preclinical Srvcs. Feb 22 Buy 23.9728 2,000 47,946 42,195 02/23/22
Taylor Beth VP- Finance & CFO VP- Finance & CFO Feb 18 Buy 23.0715 5,000 115,358 83,875 02/22/22
Davis Gregory Cole Director Director Feb 17 Buy 21.87 5,000 109,350 37,683 02/22/22
Garrett Michael Chief Commercial Off.. Chief Commercial Officer Feb 18 Buy 23.5 1,000 23,500 1,000 02/22/22
Pitchford William D Chief HR Officer Chief HR Officer Feb 18 Buy 21.12 3,500 73,920 76,174 02/18/22
Beattie John Gregory Chief Operating Offi.. Chief Operating Officer Feb 16 Buy 22.93 11,400 261,402 42,794 02/18/22
Leasure Robert Jr. President and CEO President and CEO Feb 17 Buy 23.0262 5,000 115,131 285,216 02/17/22
Sagartz John E Chief Strategy Offic.. Chief Strategy Officer Feb 15 Buy 19.95 2,506 49,995 681,030 02/17/22
Johnson Richard Allen Director Director Aug 02 Option 1.4 25,000 35,000 67,683 02/07/22
Downing Philip A Sr. VP, Preclinical.. Sr. VP, Preclinical Srvcs. Dec 22 Sell 43.0412 3,057 131,577 40,195 01/12/22